Engineered T Lymphocytes Show Therapeutic Potential Against High-Grade Serous Ovarian Carcinoma
A comprehensive literature review evaluates engineered T-cell therapies, including CAR-T and TCR-T platforms, for overcoming therapeutic resistance in high-grade serous ...




